Cargando…

BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells

To decrease bowel cancer incidence and improve survival, we need to understand the mechanisms that drive tumorigenesis. Recently, B-cell lymphoma 3 (BCL-3; a key regulator of NF-κB signalling) has been recognised as an important oncogenic player in solid tumours. Although reported to be overexpresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Legge, Danny N., Shephard, Alex P., Collard, Tracey J., Greenhough, Alexander, Chambers, Adam C., Clarkson, Richard W., Paraskeva, Christos, Williams, Ann C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451435/ https://www.ncbi.nlm.nih.gov/pubmed/30792270 http://dx.doi.org/10.1242/dmm.037697

Ejemplares similares

The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis
por: Legge, Danny N, et al.
Publicado: (2020)

BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor beta [TGF-β1] in colorectal tumour cells
por: Skeen, Victoria R., et al.
Publicado: (2012)

BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling
por: Urban, Bettina C, et al.
Publicado: (2016)

5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis
por: Dixon, Steven William, et al.
Publicado: (2021)

β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin?
por: Smartt, H J M, et al.
Publicado: (2012)

Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells
por: Morgan, R G, et al.
Publicado: (2015)

Circulating prostaglandins as biomarkers for colorectal cancer?
por: Greenhough, Alexander, et al.
Publicado: (2015)

The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells
por: Qualtrough, David, et al.
Publicado: (2015)

The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells
por: Greenhough, Alexander, et al.
Publicado: (2010)

BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination
por: Parker, Christopher, et al.
Publicado: (2022)

Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
por: Hoskin, Ashley J., et al.
Publicado: (2023)

LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity
por: Morgan, R G, et al.
Publicado: (2018)

The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
por: de la Roche, Marc, et al.
Publicado: (2008)

Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
por: Greenhough, Alexander, et al.
Publicado: (2018)

The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells
por: Collard, T J, et al.
Publicado: (2012)

Tuning WNT-β-catenin signaling via BCL9 proteins for targeting colorectal cancer cells
por: Beaulieu, Jean-François
Publicado: (2015)

Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells
por: Guy, M, et al.
Publicado: (2001)

Optimized delivery of siRNA into 3D tumor spheroid cultures in situ
por: Morgan, R. G., et al.
Publicado: (2018)

Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines
por: Playle, L C, et al.
Publicado: (2002)

LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells
por: Morgan, Rhys G., et al.
Publicado: (2019)

Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
por: Wakefield, A, et al.
Publicado: (2008)

BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis
por: Southern, Samantha L., et al.
Publicado: (2011)

Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
por: Holt, Amy K., et al.
Publicado: (2023)

BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer
por: Moor, Andreas E., et al.
Publicado: (2015)

Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer
por: Chen, Xi, et al.
Publicado: (2020)

Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1)
por: Greenhough, Joanna, et al.
Publicado: (2016)

Selective killing of contaminating human fibroblasts in epithelial cultures derived from colorectal tumours using an anti Thy-1 antibody-ricin conjugate.
por: Paraskeva, C., et al.
Publicado: (1985)

miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling
por: Sun, Naihui, et al.
Publicado: (2020)

Bcl-w expression in colorectal adenocarcinoma
por: Wilson, J W, et al.
Publicado: (2000)

Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.
por: Ofner, D., et al.
Publicado: (1995)

Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction
por: Lickliter, J D, et al.
Publicado: (2007)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Tumour–stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness
por: Le, N H, et al.
Publicado: (2008)

Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin
por: Lee, Woo Sang, et al.
Publicado: (2013)

β-catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl
por: ZHANG, JIN, et al.
Publicado: (2016)

Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling
por: Or, Chi-Hung R., et al.
Publicado: (2020)

Are different events involved in the development of sporadic versus hereditary tumours? The possible importance of the microenvironment in hereditary cancer.
por: Paraskeva, C., et al.
Publicado: (1990)

Gastrin stabilises β-catenin protein in mouse colorectal cancer cells
por: Song, D H, et al.
Publicado: (2005)

METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of β-catenin/NANOG
por: Sun, Chun-Lei, et al.
Publicado: (2023)

Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T(reg) cells
por: Feng, M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_69vm81ttam4n1vo50hh9dv87tc